1.Effect of Sinitang Combined with Targeted Therapy and Immunotherapy on Enterohepatic Circulation of Bile Acid in Patients with Liver Cancer
Yi SHI ; Yalan QIU ; Mengmeng CAI ; Peipei HUANG ; Jingdong GAO ; Ting CHEN
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(24):120-128
ObjectiveTo observe the clinical efficacy of Sinitang combined with lenvatinib mesylate and sintilizumab in treating liver cancer and the effects on the cholesterol metabolism and intestinal flora structure in the patients, thus preliminarily exploring the regulatory effect on hepatoenteric circulation of bile acid. MethodsEighty liver cancer patients treated in Suzhou Hospital of Traditional Chinese Medicine were selected and randomly allocated to control and observation groups, with 40 patients in each group. The control group was treated with lenvatinib mesylate combined with sintilimab, and the observation group additionally received Sinitang granules for three months. The Karnofsky Performance Status (KPS) score, traditional Chinese medicine (TCM) syndrome efficacy, TCM syndrome score, and computed tomography/magnetic resonance imaging (CT/MRI) imaging results of the two groups before and after treatment were compared. The serum levels of total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and total bile acid (TBA) were assayed. The 16S rDNA sequencing technique was used to detect the changes of intestinal flora structure characteristics and the correlation between differential taxa and TBA in the two groups before and after treatment. ResultsAfter treatment, the KPS scores of the two groups increased (P<0.05,P<0.01), and the change was more pronounced in the observation group (P<0.01). Following treatment, TCM symptom scores in the observation group declined (P<0.01). The total response rate of TCM syndrome alleviation in the observation group was 82.50%(33/40), exceeding that (55.00%, 22/40) of the control group (χ2=7.040, P<0.05). Post-treatment CT/MRI findings in the observation group tended to be better than those in the control group, although the inter-group difference did not reach statistical significance. After treatment, the observation group showed increases in the number of gut microbial taxa at the phylum, order, family, genus, and species levels (P<0.05). In addition, the observation group exhibited declined serum TC, TG, and LDL-C levels (P<0.05) and TBA level (P<0.01), whereas the HDL-C level increased slightly. After Sinitang treatment, the diversity of intestinal flora in patients with liver cancer increased. The relative abundance of Comamonas decreased, and that of f__Planococcaceae_Unclassified, differed significantly before and after treatment,while f__Oscillospiraceae_Unclassified, and Christensenellaceae_R-7_group increased (P<0.05). The differential bacterial species demonstrated a strong correlation with TBA (P<0.05). ConclusionSinitang combined with targeted therapy and immunotherapy can improve the clinical status of patients with liver cancer and regulate cholesterol metabolism and intestinal flora structure by regulating the enterohepatic circulation of bile acid.
2.Development of a risk prediction score scale for late-onset sepsis in very low birth weight infants
Qianwen XIA ; Dan LI ; Lili YAO ; Yi GONG ; Mengfan QIU ; Fan WAN ; Yaoyao DONG ; Ruolin REN ; Yalan DOU ; Lin YUAN ; Xiaojing HU
Chinese Pediatric Emergency Medicine 2025;32(3):161-169
Objective:To analyze the predictive factors associated with late-onset sepsis(LOS) in very low birth weight infants,and to develop a risk prediction score scale applicable to these infants three days postnatal.This will provide valuable insights for early diagnosis and timely intervention.Methods:Very low birth weight infants admitted to the Children's Hospital of Fudan University from January 1,2022,to June 30,2024,were selected as research subjects.These infants were categorized into two groups:the LOS group and the non-LOS group,based on whether they developed LOS.LASSO regression analysis,alongside univariate and multivariate regression analyses,was employed to identify predictive factors for LOS in this population.A Logistic model was constructed using the optimal combination of predictive variables,and a risk assessment scale was subsequently developed.The prediction performance of the model was evaluated using the Hosmer-Lemeshow chi-square test and the receiver operating characteristic curve.Results:A total of 444 cases of very low birth weight infants were included,of which 185 had LOS and 259 did not.After screening the variables,seven independent factors were included into the model:birth weight,gestational age,tracheal intubation,abnormal skin color,abdominal distension,elevated C-reactive protein levels,and right hand perfusion index.A predictive scoring scale was developed based on the regression coefficients of each variable,with corresponding risk scores assigned as follows:1,4,3,2,1,1,and 2; a score of ≥3.5 indicated high-risk groups.The Hosmer-Lemeshow test results demonstrated that χ2 = 7.602( P = 0.473).The area under the receiver operating characteristic curve was 0.792 ( P<0.001),with a sensitivity of 73.5% and specificity of 71.0%. Conclusion:The risk score scale developed in this study exhibits significant predictive capability,providing valuable insights for clinical medical personnel to assess the risk of LOS in very low birth weight infants during the early postnatal period.
3.Development of a risk prediction score scale for late-onset sepsis in very low birth weight infants
Qianwen XIA ; Dan LI ; Lili YAO ; Yi GONG ; Mengfan QIU ; Fan WAN ; Yaoyao DONG ; Ruolin REN ; Yalan DOU ; Lin YUAN ; Xiaojing HU
Chinese Pediatric Emergency Medicine 2025;32(3):161-169
Objective:To analyze the predictive factors associated with late-onset sepsis(LOS) in very low birth weight infants,and to develop a risk prediction score scale applicable to these infants three days postnatal.This will provide valuable insights for early diagnosis and timely intervention.Methods:Very low birth weight infants admitted to the Children's Hospital of Fudan University from January 1,2022,to June 30,2024,were selected as research subjects.These infants were categorized into two groups:the LOS group and the non-LOS group,based on whether they developed LOS.LASSO regression analysis,alongside univariate and multivariate regression analyses,was employed to identify predictive factors for LOS in this population.A Logistic model was constructed using the optimal combination of predictive variables,and a risk assessment scale was subsequently developed.The prediction performance of the model was evaluated using the Hosmer-Lemeshow chi-square test and the receiver operating characteristic curve.Results:A total of 444 cases of very low birth weight infants were included,of which 185 had LOS and 259 did not.After screening the variables,seven independent factors were included into the model:birth weight,gestational age,tracheal intubation,abnormal skin color,abdominal distension,elevated C-reactive protein levels,and right hand perfusion index.A predictive scoring scale was developed based on the regression coefficients of each variable,with corresponding risk scores assigned as follows:1,4,3,2,1,1,and 2; a score of ≥3.5 indicated high-risk groups.The Hosmer-Lemeshow test results demonstrated that χ2 = 7.602( P = 0.473).The area under the receiver operating characteristic curve was 0.792 ( P<0.001),with a sensitivity of 73.5% and specificity of 71.0%. Conclusion:The risk score scale developed in this study exhibits significant predictive capability,providing valuable insights for clinical medical personnel to assess the risk of LOS in very low birth weight infants during the early postnatal period.
4.Construction and application of a family integrated care program for very low birth weight infants in China
Mengfan QIU ; Yi ZHANG ; Liling LI ; Yun CAO ; Yalan DOU ; Xiaojing HU
Chinese Journal of Nursing 2024;59(24):2957-2965
Objective To develop a comprehensive family integrated care program for very low birth weight in-fants and to investigate the initial application effect of the program.Methods The family integrated care program for very low birth weight infants was developed using semi-structured interviews,a comprehensive literature review,and an expert consensus.A non-synchronous controlled trial was subsequently carried out.Between January and May 2023,35 participants accompanied by their parents for a minimum of 6 hours daily over a span of at least 3 days,were consecutively selected as an intervention group.Between January and May 2022,35 participants in the control group were treated with routine closed neonatal intensive care unit model.The application effect of the pro-gram on the clinical outcomes of very low birth weight infants was assessed,such as weight gain rate during hospi-talization,breastfeeding days,incidence of late-onset sepsis,incidence of extrauterine growth restriction at discharge,TIMP level at corrected gestational age of 37 weeks and hospitalization days.Results The authority coefficient of the 8 invited experts specializing in neonatal nursing and nursing management was 0.925.A comprehensive pro-gram was developed,consisting of 2 stages—preparation and implementation,and addressing 7 key themes:staff team formation and training,environmental support,assessment,parental training,family-integrated care implementation,peer support,and comprehensive communication.No shedding cases occurred during the application of the program.The outcomes indicated that the intervention group experienced a higher rate of weight gain and more days of breast-feeding compared to the control group,and the incidence of extrauterine growth retardation upon discharge was also lower,with statistically significant differences(all P<0.05).However,there were no significant differences in other clinical outcomes(all P>0.05).Conclusion The family integrated care program for very low birth weight infants de-veloped in this study is scientifically grounded,comprehensive,and practical.The implementation of this program can promote the weight gain and breastfeeding among very low birth weight infants,reduce the occurrence of extrauter-ine growth restriction upon discharge,and does not increase the incidence of late-onset sepsis.
5.Construction and application of a family integrated care program for very low birth weight infants in China
Mengfan QIU ; Yi ZHANG ; Liling LI ; Yun CAO ; Yalan DOU ; Xiaojing HU
Chinese Journal of Nursing 2024;59(24):2957-2965
Objective To develop a comprehensive family integrated care program for very low birth weight in-fants and to investigate the initial application effect of the program.Methods The family integrated care program for very low birth weight infants was developed using semi-structured interviews,a comprehensive literature review,and an expert consensus.A non-synchronous controlled trial was subsequently carried out.Between January and May 2023,35 participants accompanied by their parents for a minimum of 6 hours daily over a span of at least 3 days,were consecutively selected as an intervention group.Between January and May 2022,35 participants in the control group were treated with routine closed neonatal intensive care unit model.The application effect of the pro-gram on the clinical outcomes of very low birth weight infants was assessed,such as weight gain rate during hospi-talization,breastfeeding days,incidence of late-onset sepsis,incidence of extrauterine growth restriction at discharge,TIMP level at corrected gestational age of 37 weeks and hospitalization days.Results The authority coefficient of the 8 invited experts specializing in neonatal nursing and nursing management was 0.925.A comprehensive pro-gram was developed,consisting of 2 stages—preparation and implementation,and addressing 7 key themes:staff team formation and training,environmental support,assessment,parental training,family-integrated care implementation,peer support,and comprehensive communication.No shedding cases occurred during the application of the program.The outcomes indicated that the intervention group experienced a higher rate of weight gain and more days of breast-feeding compared to the control group,and the incidence of extrauterine growth retardation upon discharge was also lower,with statistically significant differences(all P<0.05).However,there were no significant differences in other clinical outcomes(all P>0.05).Conclusion The family integrated care program for very low birth weight infants de-veloped in this study is scientifically grounded,comprehensive,and practical.The implementation of this program can promote the weight gain and breastfeeding among very low birth weight infants,reduce the occurrence of extrauter-ine growth restriction upon discharge,and does not increase the incidence of late-onset sepsis.
6.Changes of peripheral perfusion index in very low birth weight infants with late-onset sepsis
Wei HUA ; Yi GONG ; Lili YAO ; Mengfan QIU ; Qianwen XIA ; Yalan DOU ; Xiaojing HU ; Guoying HUANG
Chinese Pediatric Emergency Medicine 2023;30(5):321-326
Objective:To analyze the changes of peripheral perfusion index (PPI) with late-onset sepsis (LOS) in very low birth weight infants during hospitalization.Methods:Very low birth weight infants admitted to the neonatal intensive care unit of Children′s Hospital of Fudan University from August 1, 2021 to August 31, 2022 were consecutively included.Infants with admission age ≥three days and unstable circulation, or positive blood culture within three days after birth were excluded.From the day of admission, the PPI values of the right hand and either foot of the infants were measured with Masimo SET Radical-7 everyday while whether LOS occurred during hospitalization was observed.The mean PPI curve of very and extremely low birth weight infants without LOS was plotted.For those with LOS confirmed by blood culture, the PPI change trajectory three days before and after the occurrence of LOS was drawn, and the change trend of PPI before the occurrence of LOS was analyzed by trend chi-square test.Non-parametric test was used to analyze the effect of LOS on pre- and post-ductal PPI values.Results:A total of 107 very low birth weight infants were included in the final analysis.Among them, there were 11 infants confirmed as LOS by blood culture, 37 infants diagnosed as clinical LOS, and 59 infants without LOS.Pre-and post-ductal PPI values of very low birth weight infants without LOS were 2.06±1.30 and 1.72±0.92, respectively; those with clinical LOS were 1.90±0.94 and 1.58±0.83, respectively; those with LOS confirmed by blood culture were 1.92±1.11 and 1.62±0.82, respectively.For infants with LOS confirmed by blood culture, the pre-and post-ductal PPI values showed a continuous downward trend during three days before the onset of disease, with the lowest PPI values on the first day before the diagnosis of blood culture.The downtrend of pre-ductal PPI was statistically significant ( χtrend2=5.57, P<0.05). Conclusion:The PPI value of very low birth weight infants show a downward trend when LOS occurs.It should be observed dynamically in clinical practice, which is helpful to suspect or identify LOS as early as possible.
7.BMAL1 functions as a cAMP-responsive coactivator of HDAC5 to regulate hepatic gluconeogenesis.
Jian LI ; Sihan LV ; Xinchen QIU ; Jiamin YU ; Junkun JIANG ; Yalan JIN ; Wenxuan GUO ; Ruowei ZHAO ; Zhen-Ning ZHANG ; Chao ZHANG ; Bing LUAN
Protein & Cell 2018;9(11):976-980
ARNTL Transcription Factors
;
deficiency
;
metabolism
;
Animals
;
Cyclic AMP
;
metabolism
;
Gluconeogenesis
;
Glucose
;
biosynthesis
;
HEK293 Cells
;
Histone Deacetylases
;
metabolism
;
Humans
;
Liver
;
metabolism
;
Mice
;
Mice, Knockout
8.The Killing Effects and Preliminary Mechanism of Natural Plant-derived Antimicrobial Solution(PAMs)to Human Liver Cancer HEPG-2 Cells
Jinyi QIU ; Jiaming HUANG ; Yijie ZHOU ; Rongkun DOU ; Zhenfei BI ; Yalan YANG ; Yinsong DONG ; Danzhou XIANGFEI ; Canquan MAO
Progress in Modern Biomedicine 2017;17(26):5011-5016
Objective:In this study,a series of experiments were conducted to research the mechanism of anticancer and preliminary molecular effects of PAMs on the HEPG-2 cancer cells.Methods:Morphological observation and MTT assay were used to explore the inhibition and killing effect of PAMs acting on HEPG-2.AO/EB staining and Annexin V-FITC/PI staining were employed to observe the apoptosis of HEPG-2 treated with PAMs.The expression level of Foxm1,bcl-2 and others genes in HEPG-2 cells were detected by using qRT-PCR and western blot.Wound healing and transwell experiments determined if PAMs can inhibit the migration of HEPG-2.Results:PAMs can inhibit and kill HEPG-2 cells in time and dose-dependent manners,and the cytotoxic effects were closely related to the cell apoptosis.The mRNA expression of foxm1,bcl-2 and surviving gene were remarkably decreased in HEPG-2 cells after the treatment of PAMs.PAMs decreased the FoXM1 protein expression in HEPG-2 cells,while up-regulating thep53 protein expression.,and it could also inhibit the migration of cancer cells.Conclusions:The possible molecular mechanism for the killing of HEPG-2 cancer cells by PAMs was proposed.By down-regulating the expression of foxm1 and up-regulating the expression of p53,the transcriptional expression of their downstream target genes survivin and bcl-2 was inhibited or reduced,hence enhancing the cancer cell apoptosis.This study provides an important foundation for the development of anti-cancer Chinese folk medicine based on PAMs.
9.Virtual screening and molecular simulations of antisense peptides targeting MT1-MMP.
Li ZENG ; Bowen TAN ; Yalan YANG ; Jinyi QIU ; Lili XIONG ; Canquan MAO
Chinese Journal of Biotechnology 2015;31(2):269-280
Membrane type-1 matrix metalloproteinase (MT1-MMP or MMP14) plays the pivotal role in tumor development and metastasis, so it is a promising drug target in malignancy. To acquire MT1-MMP specific binding peptides, we first analyzed MMPs sequences to find the divergent and specific sequence of MT1-MMP by bioinformatics approach, then set the specific sequence as the sense peptide target and designed antisense peptide library. Finally, by means of molecular docking, molecular dynamics simulation and in vitro cell assays, we screened the antisense peptide library against MT1-MMP and further studied the obtained specific peptides. Here, we identified the divergent and specific sequence of AYIREGHE (Named MT1-loop) located in MT1-MMP loop by multiple sequence alignment and established the antisense peptides library with capacity of 1 536 sequences. After two rounds of virtual screening, we obtained five antisense peptides with Rerankscores in the top for further screening. They all interacted with MT1-MMP, and docked well at the active site composed of MT1-loop sequence. Analysis of the affinities of these five antisense peptides to other MMPs (MMP1-3, MMP7-13, MMP14 HPX, MMP16) revealed that the peptide FVTFPYIR was more specific to MT1-MMP. Molecular dynamics simulation showed that the peptide FVTFPYIR might affect the stability of MT1-MMP and thus have effects on its activities. Meanwhile, the peptide FVTFPYIR could specifically inhibit the growth of MG63 and MDA-MB-231 tumor cells both of which expressed MT1-MMP. The work provides a new insight and way for the development of antitumor lead peptides targeting MT1-MMP.
Amino Acid Sequence
;
Humans
;
Matrix Metalloproteinase 14
;
chemistry
;
Molecular Dynamics Simulation
;
Neoplasms
;
Peptide Library
;
Peptides
;
chemistry
10.Promotion of apoptosis in leukemia K562 cells by natural plant-derived antimicrobial solution(PAMs)
Yijie ZHOU ; Rongkun DOU ; Zhenfei BI ; Yalan YANG ; Zongying LIU ; WU WU ; Jinyi QIU ; Danzhou XIANGFEI ; Canquan MAO
Journal of China Pharmaceutical University 2015;46(6):712-718
In this study, the leukemia K562 cell line was used as a model to elucidate the anticancer effects and preliminary mechanisms of PAMs. MTT assay showed that PAMs could cause cytotoxicities in K562 cells in dose- and time-dependent manners. AO-EB, Annexin-FITC/PI staining showed that the killing effects of PAMs in K562 cells were related to apoptosis, which was further confirmed by the following molecular and enzymatic assay. The mRNA levels of pro-apoptotic genes caspase-3, caspase-9 and bax were remarkably increased while the anti-apoptotic gene bcl-2 was significantly decreased determined by fluorescent quantitative PCR. Western blotting disclosed that PAMs could up-regulate caspase-3 and down-regulate anti-apoptotic survivin protein expression. The latter was also consistent with the results that PAMs could increase the enzymatic activities of both caspase-3 and caspase-9. All these results suggested that PAMs could effectively inhibit the proliferation of K562 cells and the mechanisms may be closely related to apoptosis induction. The work provides evidence basis for PAMs to be potentially developed as anti-cancer leukemia Chinese medicine.

Result Analysis
Print
Save
E-mail